http://www.bing.com/news/search?q=Antiobesity+Drug&form=QBNR&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=Antiobesity+Drug&form=QBNR&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.aol.com%2farticles%2fanti-obesity-drug-improves-metabolism-150700033.html&c=4570997162858455749&mkt=en-usThe skin over a mouse’s shoulders warmed up after a dozen days on tirzepatide. That heat map, taken with an infrared camera, pointed to a familiar patch of tissue between the shoulder blades: brown ...Tue, 24 Feb 2026 16:01:00 GMTAOLhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fmarkets%2fnovo-nordisk-is-now-offering-its-anti-obesity-drug-for-as-low-as-199-per-month%2far-AA1QCZIE&c=8518125581840648420&mkt=en-usNovo Nordisk (NYSE: NVO) has announced sweeping price cuts for its blockbuster GLP-1 drugs, Wegovy and Ozempic, offering patients access to the lowest doses for just $199/month. New cash-paying ...Mon, 17 Nov 2025 18:14:00 GMTMSNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.medscape.com%2fviewarticle%2fhow-policy-and-new-drugs-reshaped-obesity-treatment-2026a100071o&c=7502739769433558789&mkt=en-usAmong patients with overweight or obesity and obesity-related comorbidities, use of antiobesity medications increased substantially after the American Medical Association (AMA) declared obesity a ...Sun, 08 Mar 2026 17:00:00 GMTMedscapehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.aol.com%2farticles%2fforget-altimmune-proven-obesity-drug-220000630.html&c=11679633879441508437&mkt=en-usThe weight-loss drug market has experienced incredible momentum over the past few years, and according to analyst projections, it hasn't peaked yet -- far from it. Among the many drugmakers looking to ...Wed, 25 Feb 2026 16:00:00 GMTAOLhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.morningstar.com%2fnews%2fdow-jones%2f202601024534%2fhealth-care-up-on-anti-obesity-drug-sales-outlook-health-care-roundup&c=10341360859806585733&mkt=en-usHealth-care companies rose as traders bet the launch of anti-obesity drug pills would spur pharmaceutical sales. Shares of weight-control drug makers Novo Nordisk and Eli Lilly rose. Celltrion shares ...Fri, 02 Jan 2026 06:08:00 GMTMorningstarhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fthis-obesity-stock-could-more-than-double-over-the-next-12-months-according-to-wall-street%2far-AA21L3Bs&c=13850091887512935461&mkt=en-usMost investors currently see the glass on this stock as being half-empty. Analysts, however, still view the glass as at least half-full.Sun, 26 Apr 2026 08:02:00 GMTThe Motley Fool on MSNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fus-could-spend-1-trillion-on-medications-on-top-weight-loss-drugs%2far-AA2286K8&c=10760031182067130308&mkt=en-usAmericans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on prescription drugs this year.Fri, 01 May 2026 06:49:07 GMTNets Wire on MSNhttp://www.bing.com/th?id=ORMS.479f6e3219f9d187a196723b44ec7224&pid=Newsw={0}&h={1}&c=1420911176http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.usatoday.com%2fstory%2fmoney%2f2026%2f02%2f22%2fwegovy-challenges-hims-weight-loss-drug-copycats%2f88662632007%2f&c=4544723388081407953&mkt=en-usMany Americans seeking popular weight-loss drugs like Wegovy and Zepbound turn to telehealth companies like Hims & Hers for cheaper, compounded alternatives. Those compounded drugs were only supposed ...Sun, 22 Feb 2026 06:55:00 GMTUSA Todayhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2ftheweek.com%2fculture-life%2ffood-drink%2fhow-weight-loss-jabs-are-changing-the-way-we-eat&c=2492556023937119010&mkt=en-usBabybel, the “small, ready-to-eat industrial cheese wrapped in its signature red wax”, is an unexpected beneficiary of anti-obesity drugs, said Le Monde. Its French-owned producer Bel is investing €60 ...Wed, 17 Dec 2025 16:00:00 GMTTHE WEEKhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a07ab9b037f43859fc510de9feff591&url=https%3a%2f%2fwww.fool.com%2finvesting%2f2026%2f02%2f26%2fforget-altimmune-this-proven-obesitydrug-giant-is%2f&c=11837161234491357653&mkt=en-usAltimmune and Novo Nordisk have encountered some headwinds in recent years. Both could rebound, but one of them looks far more likely to do so. Altimmune and Novo Nordisk have both encountered ...Thu, 26 Feb 2026 13:40:00 GMTThe Motley Fool